A test that uses lab-grown mast cells is showing potential as a new and non-invasive method to diagnose food allergies.… Read more »
Author: Jenifer Goodwin
EU Poised to Approve Neffy Epi Spray – Will U.S. Soon Follow?
The first nasal epinephrine spray for the treatment of allergic reactions is poised to become available in Europe in late… Read more »
Therapy Aims to Turn IgE Allergy Antibodies into Reaction Blockers
A biotech company has developed a technique that transforms the antibodies that trigger allergic reactions into reaction blockers. Their first… Read more »
Hunting for the Missing Link Between Eczema and Food Allergies
Many kids with food allergies follow a similar path. As babies, their skin is red and inflamed from eczema. Then,… Read more »
4 Epi Auto-Injector Alternatives Make Progress, Aim for Approval
Four companies are making progress on needle-free epinephrine auto-injector alternatives for treating serious allergic reactions. Contenders include two nasal sprays,… Read more »
Nanoparticles Targeting Mast Cells Prevent Allergic Reactions in Mice
Nanoparticles that target and deactivate mast cells prevented anaphylaxis in mice, Northwestern University researchers have found. The research is in… Read more »
Boy’s Therapy Journey: From Extreme Allergies to Food Freedom
As a child, Luca Hoang’s allergies to peanuts, walnuts and hazelnuts led to several scary reactions. So when his mom… Read more »
Xolair and Food Allergy FAQ: From Doses to Risks, Insurance, OIT
Omalizumab – the brand Xolair – recently became the first medication approved by the U.S. Food and Drug Administration to… Read more »
Neffy Epi Spray: Halted Anaphylaxis in Kids, Fared Well in Hives
The nasal epinephrine sprayer called neffy reversed anaphylaxis in 15 children experiencing a serious reaction to a food allergen. The… Read more »
FDA Approves Xolair to Avert Severe Food Allergy Reactions
The Food and Drug Administration has approved omalizumab – the brand Xolair – to help those with one or more… Read more »